Most Recent Articles by James G. Dickinson
That change is coming about in the wake of a string of First Amendment-based losses for the FDA in federal courts around the country.
Would you expect that patient power exerted through social media might shake the job of a high-level FDA center director?
The FDA has to respect First Amendment limitations regulating scientific communication
Medtronic, as part of the settlement, will pay $602,000 to a whistleblower to settle charges it caused physicians to submit false claims to federal health programs.
President Barack Obama's recently unveiled Precision Medicine Initiative hopes to develop a new model of patient-driven research with the promise of accelerating biomedical discoveries and provide clinicians with new tools, knowledge, and therapies.
More Articles by James G. Dickinson
- 5 Ways to Improve the Customer Experience for Oncologists
- Healthline's traffic rises, putting it closer to WebMD and Everyday Health
- Five things for pharma marketers to know: Wednesday, August 17, 2016
- Five things for pharma marketers to know: Monday, August 22, 2016
- Five things for pharma marketers to know: Thursday, August 18, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- What do physicians think about biosimilars?
- Boehringer Ingelheim launches gamified support program
- The Science and Psychology behind Patient Engagement